Categories: 
Pharmaceutical
Report Id: PTRTM117

Testosterone is responsible for the improvement of male sexual characteristics and this hormone formed by the testicles. It is also important to maintain various functions such as sexual function, bone growth, adequate levels of red blood cells, and a sense of well being and muscle bulk. Insufficient production of testosterone causes erectile dysfunction. Erectile dysfunction occurs due to decreased testosterone production to overcome this testosterone replacement therapy is used to improve the problem. Testosterone replacement therapy occurs in various forms containing its own set of advantages and hazards such as subdemal pellets, transdemal patches and injections. Testosterone replacement therapy also helps to recover symptoms of low testosterone. Low testosterone is caused due to age growth it generally lowers down after the mid 30’s and further decreases accordingly to the age factor.

 

The major driving factors of testosterone replacement therapy market are as follows:

Rise in incidence of testosterone deficiency.
Increase in geriatric populace with high risk of testosterone deficiency.
Increasing awareness about testosterone substitute therapy.

 

The restraining factors of testosterone replacement therapy market are as follows:

High possibility of side effects associated to testosterone replacement therapy.
Patent expiry of key drugs and entry of generics.

 

The testosterone replacement therapy market is segmented on the lines of its product type and ingredient type. Based on product type the testosterone replacement therapy market is segmented into oral, implants, gums/ buccal adhesives, injections, patches and creams/ gels. The testosterone replacement therapy market is segmented on the lines of its ingredient type like testosterone, testosterone cypionate, testosterone enanthate, testosterone undecanoate and methyl testosterone. The testosterone replacement therapy marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

 

This report provides:

1) An overview of the global market for testosterone replacement therapy and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.

3) Identifications of new market opportunities and targeted promotional plans for testosterone replacement therapy.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

 

REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets of Testosterone Replacement Therapy. The reasons given for variations in the growth of the industry in certain regions.

 

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG, and Pfizer, Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

 

The Testosterone Replacement Therapy Market has been segmented as below:  

 

By Product Type Analysis

Oral
Implants
Gums/Buccal Adhesives
Injections
Patches
Creams/Gels

 

By Ingredient Type Analysis

Testosterone
Testosterone Cypionate
Testosterone Enanthate
Testosterone Undecanoate
Methyl Testosterone

 

By Regional Analysis

North America
Europe
Asia-Pacific
MEA
Rest of the World

 

Reasons to Buy this Report:

1) Obtain the most up to date information available on all testosterone replacement therapy market globally.

2) Identify growth segments and opportunities in the industry.

3) Facilitate decision making on the basis of strong historic and forecast of testosterone replacement therapy market data.

4) Assess your competitor’s refining portfolio and its evolution.

 

Customization:
We can offer you custom research reports as per client’s special requirements.

1 INTRODUCTION    
    1.1    KEY TAKE AWAYS    
    1.2    REPORT DESCRIPTION    
    1.3    MARKETS COVERED    
    1.4    STAKEHOLDERS    
    1.5    RESEARCH METHODOLOGY    
    1.5.1    MARKET SIZE    
    1.5.2    MARKET SHARE    
    1.5.3    KEY DATA POINTS FROM SECONDARY SOURCES    
    1.5.4    KEY DATA POINTS FROM PRIMARY SOURCES

2. Executive Summary
    2.1. Global Testosterone Replacement Therapy: Market Snapshot
    2.2. Global Testosterone Replacement Therapy Market Share, by Geography, 2015 & 2024 (E)
    2.3. Global Testosterone Replacement Therapy Market Revenue, by Product Type, (US$ Mn), 2015
    2.4. Global Testosterone Replacement Therapy Market Revenue, by Active Ingredient, (US$ Mn), 2015

3. Global Testosterone Replacement Therapy Market – Industry Analysis
    3.1. Introduction
    3.2. Market Dynamics
          3.2.1. Market Drivers
                  3.2.1.1. Increase in incidence of testosterone deficiency
                  3.2.1.2. Rise in geriatric population with high risk of testosterone deficiency
                  3.2.1.3. Growing awareness about testosterone replacement therapy
          3.2.2. Restraints
                  3.2.2.1. High risk of side effects related to testosterone replacement therapy
                  3.2.2.2. Patent expiry of key drugs and entry of generics
          3.2.3. Opportunities
3.2.3.1. Asia Pacific holds immense potential for testosterone replacement therapy
    3.3. Market Attractiveness Analysis: Global Testosterone Replacement Therapy Market, by Geography, 2015
    3.4. Pricing Analysis: Testosterone Replacement Therapy Market, by Product, (US$) 2015
    3.5. Global Testosterone Replacement Therapy Market Revenue, by Product Type, (US$ Mn), 2014–2024
          3.5.1. Overview
          3.5.2. Global Creams/Gels Market Revenue, (US$ Mn), 2014–2024
          3.5.3. Global Patches Market Revenue, (US$ Mn), 2014–2024
          3.5.4. Global Injections Market Revenue, (US$ Mn), 2014–2024
          3.5.5. Global Gums/Buccal Adhesives Market Revenue, (US$ Mn), 2014–2024
          3.5.6. Global Implants Market Revenue, (US$ Mn), 2014–2024
          3.5.7. Global Oral TRT Market Revenue, (US$ Mn), 2014–2024
    3.6. Global Testosterone Replacement Therapy Market Revenue, By Active Ingredient, (US$ Mn), 2014–2024
          3.6.1. Overview
          3.6.2. Global Testosterone Market Revenue, (US$ Mn) 2014–2024
          3.6.3. Global Methyl Testosterone Market Revenue, (US$ Mn) 2014–2024
          3.6.4. Global Testosterone Undecanoate Market Revenue, (US$ Mn) 2014–2024
          3.6.5. Global Testosterone Enanthate Market Revenue, (US$ Mn) 2014–2024
          3.6.6. Global Testosterone Cypionate Market Revenue, (US$ Mn) 2014–2024
    3.7. Competitive Landscape: Global Testosterone Replacement Therapy Market Share, by Key Players, 2015 (%)
    3.8. Pipeline Analysis: Testosterone Replacement Therapy
    3.9. TRT Technology Development Timeline

4. North America Testosterone Replacement Therapy Market Analysis
    4.1. Key Trends Analysis
    4.2. North America Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
    4.3. North America Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024

5. Europe Testosterone Replacement Therapy Market Analysis
    5.1. Key Trends Analysis
    5.2. Europe Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
    5.3. Europe Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024

6. Asia Pacific Testosterone Replacement Therapy Market Analysis
    6.1. Key Trends Analysis
    6.2. Asia Pacific Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
    6.3. Asia Pacific Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024

7. Middle East and Africa (MEA) Testosterone Replacement Therapy Market Analysis
    7.1. Key Trends Analysis
    7.2. MEA Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
    7.3. MEA Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024

8. Latin America Testosterone Replacement Therapy Market Analysis
    8.1. Key Trends Analysis
    8.2. Latin America Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
    8.3. Latin America Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024

9. Global Testosterone Replacement Therapy Market, Country Snippets
    9.1. Global Testosterone Replacement Therapy Market Revenue, by Country, (US$ Mn), 2014–2024
    9.2. U.S. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
    9.3. Japan Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
    9.4. Germany Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
    9.5. U.K. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
    9.6. Canada Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
    9.7. China Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
    9.8. Brazil Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
    9.9. Mexico Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
    9.10. United Arab Emirates (UAE) Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024

10. Company Profiles
    10.1. AbbVie, Inc.
    10.2. Allergan plc
    10.3. Bayer AG
    10.4. Endo Pharmaceuticals, Inc.
    10.5. Eli Lilly and Company
    10.6. Kyowa Kirin International plc
    10.7. Mylan N.V.
    10.8. Novartis AG
    10.9. Pfizer, Inc.

License Format Properties
Single User License The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Multi User License The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user license, allowing up to five users to have access to the product.
Corporate License The report will be emailed to you. The report is sent in PDF format. This is a 10+ user license, allowing up to 10+ users to have access to the product.
Mini Report License In this you will receive full report except the Company Profile section of this report. In this you will receive full report except the Company Profile section of this report.
Need More Information: 

Email: Sales@marketresearchengine.com

Toll Free No. : +1-855-984-1862

Call Us. : +91 86 05 657204